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Abstract Metastasis depends upon cancer cell growth and survival within the metastatic niche.
Tumors which remodel their glycocalyces, by overexpressing bulky glycoproteins like mucins,
exhibit a higher predisposition to metastasize, but the role of mucins in oncogenesis remains
poorly understood. Here we report that a bulky glycocalyx promotes the expansion of
disseminated tumor cells in vivo by fostering integrin adhesion assembly to permit G1 cell cycle
progression. We engineered tumor cells to display glycocalyces of various thicknesses by coating
them with synthetic mucin-mimetic glycopolymers. Cells adorned with longer glycopolymers
showed increased metastatic potential, enhanced cell cycle progression, and greater levels of
integrin-FAK mechanosignaling and Akt signaling in a syngeneic mouse model of metastasis. These
effects were mirrored by expression of the ectodomain of cancer-associated mucin MUC1. These
findings functionally link mucinous proteins with tumor aggression, and offer a new view of the
cancer glycocalyx as a major driver of disease progression.
DOI: https://doi.org/10.7554/eLife.25752.001
Introduction
Cell surface mucins, such as MUC1 and MUC16, are so consistently upregulated in epithelial cancers
that they are considered reliable biomarkers of the disease. (Bast et al., 2009; Rahn et al., 2001)
Despite their importance for diagnosis and prognosis, the mechanisms by which mucins might pro-
mote malignancy remain largely speculative. (Kufe, 2009a) To date, the majority of studies explor-
ing the role of mucins in determining tumor phenotype have focused on the signaling function of
these molecules, which resides within their short cytoplasmic tail. Yet, a striking and defining feature
of cell surface mucins is their long, densely glycosylated ectodomain, which can extend hundreds of
nanometers from the plasma membrane. (Hattrup and Gendler, 2008) Consequently, mucins can
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profoundly enhance the bulk physical properties of the glycocalyx, which is a composite of the poly-
saccharides and glycoproteins that project from the plasma membrane and decorate all cells.
We recently showed that the bulk physical properties of the glycocalyx can exert profound effects
on cellular behavior. These effects include a reorganization of cell surface receptors such as integrins.
This reorganization alters their activation state and influences not only their ability to interact with
extracellular matrix (ECM) ligands but also their synergistic downstream signaling with growth factor
receptors. (Paszek et al., 2014; Freeman et al., 2016) By occluding the majority of binding sites, an
expansive glycocalyx paradoxically promotes integrin clustering by creating a kinetic funnel in which
integrins are most likely to bind to the ECM where bonds are already formed. (Paszek et al., 2009)
In this regard, in vitro studies revealed that increasing the bulkiness of the glycocalyx enhanced the
ability of nonmalignant mammary epithelial cells to grow and survive under minimally adhesive con-
ditions whereas otherwise the cells underwent anoikis. (Paszek et al., 2014; Woods et al., 2015;
Desgrosellier and Cheresh, 2010) Whether a bulky glycocalyx similarly modulates cell growth and
survival in vivo, however, has yet to be unambiguously tested.
Importantly, we and others have also noted that tumor aggression is frequently associated with
an increased expression of mucins which enhance the bulkiness of the glycocalyx and, similarly, that
circulating epithelial tumor cells typically express an abundance of mucins. (Paszek et al., 2014)
Concomitantly, primary tumor xenografts that overexpress MUC1 grow and metastasize more
aggressively (Wang et al., 2015) and mice deficient in MUC1 resist formation of spontaneous
tumors (Spicer et al., 1995). Together, these observations raise the intriguing possibility that tumor
associated mucin expression may foster tumor progression and aggression by enhancing either
tumor cell growth and survival or both by modulating integrin and growth factor receptor signaling.
Herein, we report that increasing the thickness of the glycocalyx promotes tumor metastasis by
permitting cell cycle progression to facilitate cell proliferation at the metastatic site. We modulated
glycocalyx thickness both genetically through ectopic expression of a tailless (signaling defective)
MUC1 and more definitively by coating cells with synthetic glycopolymers with long-term cell surface
retention that were designed to emulate the structure of mucin ectodomains
(Figure 1A). (Woods et al., 2015) The longevity of the synthetic glycopolymers was facilitated by
developing the chemistry so that the tail terminated in a cholesterylamine lipid at one end, which
effectively drives spontaneous insertion into cell membranes based on mass action and the hydro-
phobic effect. We previously found that this particular lipid confers a long cell surface residence time
to glycopolymer conjugates by mediating continuous recycling from an internal
reservoir. (Woods et al., 2015) The core of the glycopolymer comprises N-acetylgalactosamine (Gal-
NAc) residues affixed to a poly (methyl vinyl ketone [MVK]) backbone via oxime linkages. The spac-
ing afforded by this structure approximates that of GalNAc-a-Ser/Thr clusters within native mucins.
Likewise, GalNAc-modified poly (MVK) glycopolymers emulate the physical characteristics of native
mucins such as length and stiffness. (Paszek et al., 2014) However, unlike the more complex glycans
found in native mucins, which can engage in biochemical interactions, (Hudak et al., 2014) the Gal-
NAc residues we used here are considered biochemically inert in mammalian systems. Thus, these
synthetic structures allowed us to model mucins’ biophysical contribution to the glycocalyx without
any confounding contributions from their cytosolic or extracellular biochemical activity. As well, the
living polymerization chemistry used to generate the glycodomains enabled precise control of poly-
mer length with high homogeneity. (Godula et al., 2009) Living polymerization techniques allow for
the synthesis of polymers of very homogeneous lengths, a necessity for the comparison of the
effects of long and short polymers. In this work, we used short glycopolymers of ~3 nm in length
(degree of polymerization (DP) = 36 monomer units) and long glycopolymers that were ~90 nm in
length (DP = 719 monomer units). As a point of comparison, integrin heterodimer pairs extend
roughly 20 nm from the cell membrane (Figure 1A). (Eng et al., 2011)
Results
Metastasis is a multistep process that requires cancer cells to overcome many checks to their irregu-
lar growth – limited not only by ability to disseminate but also to survive and thereafter to grow and
expand at the metastatic site. The nonmalignant mammary epithelial cell line, MCF-10A, offers a
unique model for oncogenic progression. (Miller et al., 1993) These cells, though immortal, lack the
ability to grow or survive efficiently in a soft matrix, and therefore serve as an ideal cell line to
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Figure 1. The glycocalyx increases metastatic potential in a size dependent manner. (A) Mucin-mimetic glycopolymers consist of a poly(methyl vinyl
ketone) polymer with pendant GalNAc residues. The glycopolymer terminates in a synthetic sterol for insertion into cell membranes. Precise synthetic
control allows for glycopolymers to be made much larger or smaller than integrins. (B) Glycopolymers reside on 4TO7 cell surfaces for days. (C)
Experimental scheme for Figure 1. Balb/c mice were injected with syngeneic 4TO7 mammary carcinoma cells bearing long or short glycopolymers. Tail
vein injections lead cells to the capillary beds of the lungs where subsequent metastatic growth can be observed. (D) Bioluminescence Imaging (BLI) of
mice injected with either long or short glycopolymer-bearing cells. (E) and (F) Gross appearance of lungs excised from mice at 15 days post injection.
(G) and (H) H and E staining and IHC labeling for mApple indicating presence of exogenously introduced cells. (I) Lungs excised during necropsy were
weighed, wet, before fixing. (J) Frank mets were counted on whole lung sections at 5 mm into sectioning for each mouse and grouped according to
glycopolymer treatment type of injected cells. (K) IF staining of mets for the mitotic marker pH3 or apoptotic marker CC3 in green. DAPI nuclear
staining is shown in blue. (L) and (M) Quantification of IF signal. For pH3, shown is the quotient of positive over total nuclei. For CC3, total signal was
normalized to the average signal per nuceli in mets from short glycopolymer treated cells. For both L and M, shown is the mean ±SEM of three mice
per group from which 3–4 tumors were averaged each. For I and J, shown is the mean ±SEM of n = 6 for mice injected with short glycopolymer-treated
cells and n = 5 for mice injected with long glycopolymer-treated cells. Scale bars are 100 mm. *p<0.05, **p<0.01 (Student’s paired t-test).
Figure 1 continued on next page
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evaluate the effects of the glycocalyx on mammary epithelial cell behavior in the context of a meta-
static site. (Paszek et al., 2005) Our prior studies suggested that a bulky glycocalyx permitted not
only the survival but also the growth of these mammary epithelial cells in an in vitro model of a mini-
mally adhesive microenvironment. Thus, we asked whether a bulky glycocalyx would permit both the
survival and the growth and expansion of disseminated mammary epithelial cells in vivo. MCF-10A
cells were painted with our glycopolymers, then injected into the venous system of nude mice,
where they accumulated in the lungs regardless of glycopolymer length. We found that those cells
treated with long glycopolymer mucin-mimetics survived longer, as demonstrated by delayed activa-
tion of the apoptosis marker cleaved caspase-3 (CC3), than those decorated with short glycopoly-
mers (Figure 1—figure supplement 1), consistent with our in vitro studies. Nevertheless, the cells
eventually died and therefore ultimately failed to form metastatic lesions, leaving us unable to deter-
mine the potential effect of the glycocalyx on proliferation. Thus, to unambiguously address whether
or not a bulky glycocalyx might influence tumor behavior and metastasis by regulating cell prolifera-
tion, independent of cell survival, we assessed the influence of the glycopolymers on the growth and
metastatic efficiency of the dormant-prone tumor cell line from the syngeneic 4TO7/Balbc model.
The murine cell line 4TO7 is a Balb/c syngeneic mammary carcinoma that is able to efficiently dis-
seminate and survive for prolonged periods of time at metastatic sites such as the
lung. (Aslakson and Miller, 1992) However, the tumor cells in this model form predominately dor-
mant tumors because they are unable to proliferate efficiently at the target site. These 4TO7 cells,
therefore, provided us the ideal model to specifically address the contribution of a bulky glycocalyx
on cell proliferation and G1 cell cycle transit in vivo.
The glycocalyx increases metastatic potential in a size dependent
manner
We first confirmed that the mucin-mimetic glycopolymers were long-lived on 4TO7 cell surfaces in
culture, as previously found with other cell lines (Figure 1B). (Woods et al., 2015) Next, we grew
mApple-luciferase fusion-transfected 4TO7 cells to subconfluency, painted them with glycopolymers,
then injected them into the tail veins of Balb/c mice (Figure 1C). Veins lead directly to the right heart
where cells next meet the capillary beds of the lungs and are lodged. Every 4–5 days mice were
anesthetized and given an intraperitoneal (IP) injection of luciferin for bioluminescence imaging (BLI)
(Figure 1D). By day 13, mice injected with 4TO7 cells coated with long glycopolymers were generat-
ing greater photon flux, on average, than their counterparts injected with short glycopolymer-
treated cells, suggesting a higher density of luciferase-expressing cells and thus an increased tumor
burden (Figure 1D and Figure 1—figure supplement 2). In particular, we noted that the increase in
BLI over time in the long glycopolymer group appeared to approximate an exponential growth-type
trend, while the short group did not (Figure 1—figure supplement 2). Importantly, we measured no
significant difference in accumulation of tumor cells in the lungs between treatment groups as mea-
sured by BLI at Day 0.
On day 15, the mice were sacrificed and necropsies were performed. We observed gross differen-
ces in tumor burden between glycopolymer treatment groups (compare Figure 1E and F). Lungs
were weighed wet then fixed in 4% paraformaldehyde and embedded in paraffin wax for whole his-
tological sectioning. Hematoxylin and eosin (H and E) staining revealed qualitative differences in
tumor burden, and immunohistochemistry (IHC) staining for mApple confirmed that tumors were
Figure 1 continued
DOI: https://doi.org/10.7554/eLife.25752.002
The following figure supplements are available for figure 1:
Figure supplement 1. Long glycopolymers delay MCF-10A cell death in nude mice.
DOI: https://doi.org/10.7554/eLife.25752.003
Figure supplement 2. Long glycopolymer-bearing 4TO7 cells proliferate more rapidly in mouse lungs than those bearing short glycopolymers.
DOI: https://doi.org/10.7554/eLife.25752.004
Figure supplement 3. Short glycopolymer-bearing 4TO7 cells have no metastatic advantage over naı¨ve 4TO7 cells.
DOI: https://doi.org/10.7554/eLife.25752.005
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derived from exogenous mApple-luciferase transfected 4TO7 cells and did not arise de novo
(Figure 1G and H).
Lung tissue is spongy and consists of an abundance of negative space that can be filled with air
during respiration. Tumors, by comparison, are dense and contain relatively little negative space.
Consequently, in a vein-to-lung model of metastasis, lung mass can be a strong indicator of tumor
burden. We found that the lungs of mice injected with 4TO7 cells endowed with a bulky glycocalyx
were significantly heavier than lungs from mice injected with short glycopolymer-bearing cells
(Figure 1I). In addition to mass, we directly quantitated the number of mets per lung. For each
mouse, we counted every met in the whole lung H and E section taken five millimeters (mm) into sec-
tioning. Long glycopolymer-treated 4TO7 cells produced, on average, more than twice the number
of mets per mouse when compared to short (Figure 1J). Thus, merely increasing the thickness of the
glycocalyx was sufficient to increase the metastatic potential of otherwise poorly metastasizing
murine carcinoma cells. Importantly, the short glycopolymers did not increase the metastatic poten-
tial of 4TO7 cells when compared to mock (PBS) treated cells (Figure 1—figure supplement 3).
Metastasis is an inefficient process—few circulating tumor cells actually give rise to metastatic
tumors—and the prevailing view is that survival and proliferation at the secondary site is rate limit-
ing.(Chambers et al., 2002) Therefore, we wondered if this increased metastatic potential could be
due to increased growth, survival, or both.
Quantitative immunofluorescence (IF) imaging of phosphorylated histone H3 (pH3)—a marker of
mitosis—and cleaved caspase-3 (CC3)—a marker of apoptosis—revealed that mets from long glyco-
polymer-treated cells had higher rates of proliferation than those from cells treated with short glyco-
polymers (Figure 1K and L). But, the rates of apoptosis were similar (Figure 1K and M). While
surprising at first, given our knowledge that a thick glycocalyx improves survival in minimal adhesion
settings, we reasoned that by day 15 the survival phenotype had likely run its course—cells unable
to survive in that niche may have died days earlier. These data corroborated our BLI results and indi-
cated that the glycocalyx likely affects metastatic proliferative competency in vivo.
A thick glycocalyx drives cell cycle progression via the PI3K-Akt axis
To gain mechanistic insight into this apparent proliferative effect, we tested the effects of modulat-
ing glycocalyx thickness on cell growth in a soft matrix in vitro model. We used fibronectin-function-
alized polyacrylamide (PA) gels whose stiffness can be controlled by varying both acrylamide
concentration and crosslinking frequency. (Lakins et al., 2012) We painted MCF-10A cells with short
or long mucin-mimetic glycopolymers, or with vehicle (PBS), then plated them at low density on
fibronectin-functionalized soft PA gels (Young’s modulus = 400 Pa) so that nearly all cells were iso-
lated, minimizing cell-cell interactions. After 72 hr, we imaged the gels and quantified the number of
cells in each observed colony. The long glycopolymer-painted cells formed colonies with, on aver-
age, twice as many cells as colonies formed by the short glycopolymer-treated cells or PBS-treated
controls (Figure 2A–C). And the percentage of colonies growing beyond two cells nearly tripled for
long-glycopolymer-treated cells verses PBS-treated controls, indicating that this increase in mean
colony size was not due merely to a few large colonies (Figure 2D).
To test that this phenotype required cell-surface residence of the long glycopolymers, we com-
pared the effects of the cholesterylamine-anchored molecules, which persist on the plasma mem-
brane for several days even after cell division, with those of a phospholipid-functionalized
glycopolymer that is lost from the cell surface within several hours. (Woods et al., 2015) Cells
treated with these short-lived but equally long glycopolymers (DPPE) did not produce larger colo-
nies compared to PBS treatment alone (Figure 2—figure supplement 1). Thus, the effects measured
in Figure 2C and D are likely mediated by glycopolymers resident on the cell surface.
To further test our hypothesis that a bulky glycocalyx permits proliferation in the metastatic niche,
we analyzed markers of cell cycle progression. Cells were painted with short or long glycopolymers,
or with vehicle (PBS), then plated on either soft (Young’s modulus = 400 Pa) or stiff (Young’s modu-
lus = 60,000 Pa) fibronectin-functionalized PA gels, the latter being a positive control for integrin
activation. (Discher et al., 2005) After allowing them to adhere for 6 hr, cells were lysed and the
lysates analyzed by immunoblotting. We found that MCF-10A cells plated on stiff PA gels, which
offer a rich adhesion setting, produced higher levels of cyclin D (a protein required for cell cycle pro-
gression) and showed higher levels of pH3 than those on adhesion-poor soft gels (Figure 2E and F).
Long glycopolymer-treated cells also demonstrated increased cyclin D and pH3 levels, compared to
Woods et al. eLife 2017;6:e25752. DOI: https://doi.org/10.7554/eLife.25752 5 of 15
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Figure 2. A thick glycocalyx drives cell cycle progression via the PI3K-Akt axis. (A) and (B) Microscopy of MCF-10A cells labeled with short or long
glycopolymers, plated on soft (400 Pa) fibronectin-functionalized gels, and cultured for 72 hr. (C) Average number of cells per colony in images such as
A and B. (D) Percent of colonies containing more than 2 cells in images such as A and B. (E) Immunoblot analysis of proliferative markers in MCF-10A
cells coated with long or short glycopolymers or treated with vehicle (PBS) and plated on soft (400 Pa) or stiff (60 kPa) fibronectin-functionalized
polyacrylamide gels for six hours. (F) Western blots from E were analyzed by densitometry, their values normalized first to total protein (tubulin) then to
that of the positive control—PBS treated cells on a stiff Fn-functionalized matrix. (G) Immunoblot analysis of pAkt and pErk in MCF-10A cells serum-
starved for 72 hr, treated with long or short glycopolymers or vehicle and plated in serum-free media on soft or stiff gels for six hours, then challenged
with epidermal growth factor for 15 min, and lysed. (H) Western blots from G were quantified and normalized to total Akt then to the positive control.
Figure 2 continued on next page
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short glycopolymer- and PBS-treated cells, even on soft gels, suggesting that a thick glycocalyx
drove proliferation and cell cycle progression in this poor adhesion setting.
Integrin activation and growth factor signaling form, in logic terms, an ‘AND gate’ for cell cycle
progression in nontransformed cells. (Kuwada and Li, 2000) We sought to determine whether a
bulky glycocalyx alters this fundamental control mechanism. After serum-starving MCF-10A cells for
72 hr, we lifted them and painted them with long or short glycopolymers, or with vehicle. The cells
were plated on gels as in Figure 2E, except now in serum-free media, and then lysed after 6 hr. A
lack of growth factor signaling reduced cyclin D1 and pH3 levels to below the detection limit, even
when cells were grown on stiff gels or endowed with a bulky glycocalyx (Figure 2—figure supple-
ment 2). The underlying drivers of proliferation therefore, including growth factor signaling require-
ments, appeared to be unaltered by glycocalyx thickness in this model.
To discern the factors responsible for increased cell cycle progression in cells with thicker glycoca-
lyces, we examined Erk and Akt, the mitogen activated protein kinases (MAPKs) thought to be cen-
tral to adhesion-mediated control of cell cycle progression. (Moreno-Layseca and Streuli, 2014)
After serum starvation for 72 hr, cells were coated with glycopolymers or vehicle, and plated on PA
gels in serum-free media for 6 hr. The cells were then challenged with epidermal growth factor
(EGF) for 15 min and then lysed. A bulky glycocalyx increased Akt phosphorylation (pAkt), a proxy
for activation, on soft gels relative to that in cells with short glycopolymers, while Erk phosphoryla-
tion, however, remained unchanged (Figure 2G and H). The same effect on pAkt was seen on 4TO7
cells in vitro (Figure 2I). As well, IF analysis of tissue sections from the experiments in Figure 1
revealed increased Akt activation, as measured by staining for phosphorylated Akt substrate, in vivo
in long glycopolymer-bearing tumor cells when compared to short (Figure 2—figure supplement
3). Consistent with this finding, we repeated the colony formation experiments and found that prolif-
eration of long glycopolymer-painted cells was blocked by an inhibitor of phosphoinositol-3 kinase
(PI3K), an upstream activator of Akt, or an inhibitor of MEK—a MAPK downstream of growth factor
receptors (Figure 2—figure supplement 4). A bulky glycocalyx, therefore, seems to drive cell cycle
progression via the PI3K-Akt axis.
While 4TO7 cells in vitro did not experience significantly increased cyclin D1 expression with a
thicker glycocalyx (Figure 2—figure supplement 5), we were able to confirm the role of glycocalyx-
driven cell cycle progression in promoting metastasis in vivo by IF staining of the 4TO7 lung mets
from the experiments in Figure 1. Metastatic 4TO7 cells in vivo expressed significantly more of the
cell cycle progression marker cyclin D1 when bearing long glycopolymers verses short (Figure 2J
and K). We posit that transformed cells, such as 4TO7, in rich culture media in vitro may see only a
negligible increase in proliferative signal from a bulky glycocalyx as evidenced by the robust cyclin
D1 signal in the negative control: PBS treated 4TO7 cells on soft gels.
Figure 2 continued
(I) Immunoblot and quantification of pAkt and total Akt in 4TO7 cells in vitro treated as in G and quantified as in H except normalized to short
glycopolymer control. (J) Cyclin D1 (green) IF staining of 4TO7 mets from experiments in Figure 1. DAPI nuclear stain in blue. (K) Quantification of IF
staining normalized to the average signal per nuceli in mets from short glycopolymer treated cells. Shown in K is the mean ±SEM of three mice per
group from which 3–4 tumors were averaged each. For C, D, F, and I, shown is the mean ±SEM of three biological replicate experiments. For H, shown
is the mean ±SEM of four biological replicate experiments. Scale bars are 100 mm. *p<0.05, **p<0.01 (Student’s paired t-test).
DOI: https://doi.org/10.7554/eLife.25752.006
The following figure supplements are available for figure 2:
Figure supplement 1. Glycopolymers must be cell-surface resident to affect colony size.
DOI: https://doi.org/10.7554/eLife.25752.007
Figure supplement 2. Glycopolymers do not abolish need for growth factor signals in proliferation.
DOI: https://doi.org/10.7554/eLife.25752.008
Figure supplement 3. Long glycopolymers increase active Akt in 4TO7 lung metastases.
DOI: https://doi.org/10.7554/eLife.25752.009
Figure supplement 4. PI3K or MEK inhibitor abolishes effects of long glycopolymers on proliferation.
DOI: https://doi.org/10.7554/eLife.25752.010
Figure supplement 5. Cyclin D1 expression in 4TO7 cells in vitro.
DOI: https://doi.org/10.7554/eLife.25752.011
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A thick glycocalyx stimulates integrin-FAK mechanosignaling
Next we sought to test our hypothesis that this phenotype is driven by integrin- focal adhesion
kinase (FAK) signaling. FAK disseminates adhesion information from focal adhesions to the rest of
the cell via autophosphorylation at tyrosine 397, as well as increased phosphorylation at tyrosine
925, presumably through Src kinase activation. (Mitra et al., 2005) Western blotting with phospho-
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Figure 3. A thick glycocalyx stimulates integrin-FAK mechanosignaling. (A) Immunoblot analysis of FAK phosphorylation in MCF-10A cells coated with
long or short glycopolymers or treated with vehicle (PBS) and plated on soft (400 Pa) or stiff (60 kPa) fibronectin-functionalized polyacrylamide gels for
six hours. (B) Western blots from A were analyzed by densitometry, their values normalized first to total FAK then to that of the positive control—PBS
treated cells on a stiff fibronectin-functionalized matrix. (C) Immunoblot analysis and quantification of pFAK and total FAK in 4TO7 cells treated as in A
and quantified as in B except normalized to short glycopolymer control. D) pFAKY397 IF staining in green of mets from experiments in Figure 1. DAPI
nuclear stain in blue. (E) Quantification of IF staining in D normalized to the average signal per nuceli in mets from short glycopolymer-treated cells.
Shown is mean ±SEM of three mice per group from which 3–4 tumors were averaged each. (F) A model by which a mucin-bolstered glycocalyx may
drive proliferation. Limited ligand access due to steric hindrance establishes a kinetic funnel in which integrins are likely to bind where bonds exist
already. This drives a clustering of integrins that activates FAK which, in conjunction with EGFR, drives activation of Akt and subsequently cell cycle
progression. Blot in A is representative of at least three biological replicate experiments. Shown in B is mean ±SEM from five biological replicate
experiments. Shown in C is mean ±SEM from three biological replicate experiments. Scale bars are 100 mm. *p<0.05 (Student’s paired t-test).
DOI: https://doi.org/10.7554/eLife.25752.012
The following figure supplement is available for figure 3:
Figure supplement 1. FAK inhibitor abolishes proliferative advantage from bulky glycocalyx.
DOI: https://doi.org/10.7554/eLife.25752.013
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specific antibodies revealed that possession of a thick glycocalyx led to enhanced activation of FAK
(Figure 3A and B). These effects on FAK were mirrored by adhesion of untreated cells to a stiff
matrix. By contrast, cells coated with short glycopolymers, or left untreated, and plated on a soft
matrix showed comparatively less phosphorylation of FAK. Similar results were seen with 4TO7 cells
in vitro (Figure 3C). Reciprocally, cells treated with long glycopolymers along with a nonlethal dose
of a specific inhibitor of FAK were unable to form colonies on soft matrices, whereas vehicle
(DMSO)-treated, long glycopolymer-coated cells retained colony forming activity (Figure 3—figure
supplement 1).
To determine whether enhancement of adhesion signaling due to a bulky glycocalyx also occurs
in vivo, we probed FAK phosphorylation status in the mets from Figure 1. Long glycopolymer-
treated cells formed tumors with significantly more FAK activation than tumors formed from short
glycopolymer-bearing cells (Figure 3D and E). These data, taken with the results in Figure 2, sup-
port a model for glycocalyx-driven enhancement of proliferation in minimal-adhesion settings. A
bulky glycocalyx drives integrin clustering through kinetic funneling, leading to increased signaling
from focal adhesion-associated proteins such as FAK. In combination with growth factor signaling,
this leads to enhanced MAPK activation, such as Akt phosphorylation, which then promotes G1 cell
cycle progression through expression of proteins like the cyclins (Figure 3F).
The MUC1 ectodomain is sufficient to increase the metastatic potential
of 4TO7 cancer cells
Lastly, for physiological relevance, we evaluated the effects of a natural mucin ectodomain on the
metastatic potential of 4TO7 cells. We utilized a cytoplasmic truncation of MUC1 (MUC1DCT), the
mucin most commonly overexpressed in breast and ovarian cancers, to limit any cytoplasmic signal-
ing which might confound our results. We transfected mApple-luciferase expressing 4TO7 cells with
MUC1DCT under the control of a doxycycline (dox)-inducible promoter. We grew these cells to sub-
confluence, treated them with doxycycline (200 ng/ml) or vehicle (PBS) for 24 hr, then lifted them
and immediately injected them into Balb/c mouse tail veins (Figure 4A). As previously, mice were
monitored every 4–5 days via BLI measurements and sacrificed on day 15.
BLI photon flux revealed that MUC1DCT-expressing cells formed mets that were growing more
rapidly than those formed from MUC1DCT-negative cells (Figure 4—figure supplement 1). Whole
lung sectioning, H and E staining and IHC on mApple revealed a dramatic qualitative difference in
tumor burden (Figure 4B and C). Wet lung mass was nearly doubled in mice injected with
MUC1DCT-expressing cells versus control (Figure 4D). Nearly three times the number of mets were
formed in the lungs of mice injected with cells expressing the mucin ectodomain compared to those
that were not (Figure 4E). pH3 IF staining revealed that more than twice the number of nuclei in
MUC1DCT-expressing cells were actively mitotic. And while the values did not reach statistical signif-
icance (p=0.06), CC3 levels were trending towards lower values in MUC1DCT-expressing mets
(Figure 4F–H). Staining for pY397-FAK, cyclin D1 and pAkt substrate demonstrated that the MUC1
ectodomain increases mechanosignaling, cell cycle progression and MAPK activity in lung mets, fur-
ther supporting our model (Figure 4I–K and Figure 4—figure supplement 2). These results dramat-
ically demonstrate the effect that the mucin ectodomain can have on metastatic cells in vivo.
Discussion
Mucin overexpression is commonly observed in epithelial cancers. MUC1 in particular is overex-
pressed in ~64% of tumors of all types diagnosed each year in the U.S. (Kufe, 2009b), rendering
MUC1 one of the most prominently dysregulated genes in cancer. As a point of reference, Ras (K-,
H- and N-RAS combined) mutations are estimated to occur in 9–30% of all cancers. (Cox et al.,
2014) Hypotheses regarding the mechanism by which MUC1 overexpression drives cancer progres-
sion have focused almost entirely on biochemical interactions of its 72-residue cytosolic domain
(Kufe, 2009b), which represents <10% of the overall protein sequence. The bulk of MUC1 resides
outside the cell where it dominates the physical properties of the glycocalyx. In previous work, we
showed that this ectodomain profoundly influences focal adhesion formation, integrin signaling, and
survival in a minimal adhesion setting. (Paszek et al., 2014) But this effect alone cannot explain the
striking effect of MUC1 ectodomain expression on metastatic burden that we observed in this study
(Figure 4). Our data herein show that a bulky glycocalyx, achieved either with synthetic or natural
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mucins, also promotes proliferation in the metastatic niche. The mucin ectodomain promotes mecha-
nosignaling and enhances cell cycle progression via the PI3K-Akt axis. This model unifies the struc-
ture of mucins with their consistent overexpression in metastatic disease (Horm and Schroeder,
2013) and the correlation of their overexpression with poor prognosis. (Rahn et al., 2001;
Duffy et al., 2000; Retterspitz et al., 2010; McGuckin et al., 1995) As well, importantly, our results
imply that drugs targeting the cytoplasmic tail of MUC1 will be missing a key pathophysiologic
mechanism.
It should be noted that in addition to their physical influence, the glycans on mucins have been
found to participate in biochemical interactions. For example, sialylated mucin-associated glycans
engage the Siglec family of immunomodulatory receptors and may therefore tune the response of
critical effector cells in the tumor microenvironment. (Belisle et al., 2010; Ohta et al., 2010;
Beatson et al., 2016) Thus, mucins’ influence on cancer likely reflects many functional modalities,
each contributing differentially to various facets of disease progression. From this vantage point,
mucins are prime targets for therapeutic intervention and warrant increased focus on avenues for
their disruption.
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Figure 4. The MUC1 ectodomain is sufficient to increase the metastatic potential of 4TO7 cancer cells. (A) Experimental scheme for Figure 4. Balb/c
mice were injected with syngeneic 4TO7 mammary carcinoma cells transfected with a MUC1DCT construct under the control of a doxycycline (dox)-
inducible promoter. Cells were treated with either dox 200 ng/ml or vehicle (PBS) for 24 hr before injections. (B) and (C) Whole lung sections H and E
stained and IHC labeled for mApple indicating presence of exogenously introduced cells. (D) Lungs excised during necropsy were weighed, wet,
before fixing. (E) Frank mets were counted on whole lung sections at 5 mm into sectioning for each mouse and grouped according to treatment type of
injected cells. (F) IF staining of mets for the mitotic marker pH3 or apoptotic marker CC3 in green. DAPI nuclear staining is shown in blue. (G) and (H)
Quantification of IF signal. For pH3, shown is the quotient of positive over total nuclei. (I) Cyclin D1 and pY397-FAK IF staining of mets in green. DAPI
nuclear stain in blue. (J) and (K) Quantification of IF signal. For H, J, and K, total signal was normalized to the average signal per nuceli in mets from
PBS treated cells. Shown is mean ±SEM of three mice per group from which 3–4 tumors were averaged each. For D and E, shown is the mean ±SEM of
n = 6 for mice injected with PBS-treated cells and n = 6 for mice injected with dox-treated cells. Scale bars are 100 mm. *p<0.05, **p<0.01, ***p<0.001
(Student’s paired t-test).
DOI: https://doi.org/10.7554/eLife.25752.014
The following figure supplements are available for figure 4:
Figure supplement 1. 4TO7 cells expressing the MUC1 ectodomain proliferate more rapidly in mouse lungs than those that do not.
DOI: https://doi.org/10.7554/eLife.25752.015
Figure supplement 2. The MUC1 ectodomain increases Akt activity in 4TO7 lung metastases.
DOI: https://doi.org/10.7554/eLife.25752.016
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Materials and methods
Mucin-mimetic glycopolymers
Glycopolymers were synthesized as previously described (Woods et al., 2015). Briefly, lipid-conju-
gated RAFT agents were synthesized, from which methyl vinyl ketone was polymerized, to generate
polymers of various lengths with low polydispersities. The ketone pendant groups were functional-
ized with alkoxy-amine containing N-acetylgalactosamine monomers and purified to give the final
lipid-terminated glycopolymers.
Cell culture
MCF-10As were acquired from ATCC (CLR-10317), met the published morphological characteristics
described on ATCC, used within 30 passages, confirmed to be mycoplasma free, and maintained in
recommended media: DMEM/F12 without phenol red, supplemented to contain 5% horse serum
(Invitrogen, Carlsbad, CA), EGF (20 ng/ml from Peprotech, Rock Hill, NJ), hydrocortisone (0.5 mg/ml
from Sigma, St. Louis, MO), cholera toxin (100 ng/ml from Sigma), insulin (10 mg/ml from Sigma) and
1% penicillin/streptomycin.
4TO7 cells were a kind gift from Dr. Philip Owens (Vanderbilt University), met the morphologic
characteristics described on ATCC, used within 30 passages, confirmed to be mycoplasma free and
were maintained in DMEM with 10% FBS and 1% penicillin/streptomycin.
Glycopolymer loading onto cell surfaces
Lipid-anchored glycopolymers spontaneously insert into cell membranes due to the hydrophobic
effect and mass action. Where noted in experimental sections below, cells in suspension are mixed
with stock concentrates of aqueous solutions of glycopolymers and allowed to be labeled for 1 hr at
room temperature. The cells are then pelleted, the labeling solution aspirated, and the excess glyco-
polymers washed away by an additional dilution-pelleting step. Details of the synthesis and use of
glycopolymers used in this study can be found in Woods et al (Woods et al., 2015).
Cell surface measurement of glycopolymers
Glycopolymers bearing a biotin molecule on the terminus opposite the lipid tail were incubated with
cells. Cells were washed and incubated in warm complete media for the desired length of time, then
washed with ice-cold PBS to reduce lipid trafficking and incubated with fluorescent anti-biotin anti-
bodies at 4˚C for 20 min, then washed and analyzed by flow cytometry. More details of this method
of measuring recycling of lipid-born glycopolymers can be found in Woods et al (Woods et al.,
2015).
mApple-Luciferase transfection
4TO7 cells were stably transduced with an mApple-luciferase fusion with lentivirus (pLV). Cells were
selected by flow cytometry in the red channel for purity then used as described (Yang et al., 2004).
MUC1DCT transfection
4TO7 cells were stably transduced with reverse tetracycline-controlled transactivator (rtTA, tet-on
system) lentivirus (pLV-neo). After neomycin (100 mg/mL) selection of rtTA-integration, cells were co-
transfected (Lipofectamine 3000, Thermo Fisher, per manufacturer’s recommendation) with a trans-
poson (PiggyBac) expressing human MUC1DCT (cytoplasmic tail-deleted) and PiggyBac transposase.
Cells were selected in puromycin (1 mg/mL) for purity and then used as described (Yang et al.,
2004).
Polyacrylamide cell substrates
Fibronectin-functionalized PA substrates were synthesized as described previously with a few modifi-
cations. Briefly, methacrylate-functionalized cover glass was used with dichlorodimethylsilane-func-
tionalized cover glass to create a sandwich between which PA gels were allowed to polymerize. Gels
were functionalized with the heterobifunctional molecule N6. Fibronectin then was conjugated to
the gels via N6’s amine-coupling chemistry. Gels were rinsed and warmed with media before cells
were added.
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Colony formation experiments
MCF-10A cells were lifted with trypsin, counted, then incubated with 10 mM polymers in PBS or PBS
alone at 107 cells per ml for 1 hr at room temperature. Cells were washed, then brought up into
warm media and plated onto fibronectin-functionalized substrates. After 72 hr in culture, images
were taken from nine random fields of view each from two technical replicate gels per experimental
condition, and the experiment was replicated in entirety thrice.
Western blots
MCF-10A cells were lifted and coated with polymers as in the colony experiments. Six hours after
plating at 4.6  103 cells per cm2, the cells were rinsed with ice-cold PBS, then lysed with M-PER
lysis buffer (Thermo Fisher, Waltham, MA) containing phosphatase inhibitors and protease inhibitors.
Lysates were subjected to SDS-PAGE and transferred to nitrocellulose membranes. Primary antibod-
ies were from Cell Signaling Technology (Danvers, MA) and used as recommended. HRP-conjugated
secondary antibodies were from Cell Signaling Technology and used as recommended.
Mice
All mice were maintained in accordance with University of California Institutional Animal Care and
Use Committee guidelines under protocol AN105326. Four week old female Balb/c or nude mice
were obtained from Jackson Labs and allowed to acclimate for 2 weeks before experiments were
performed.
Tail vein metastasis model
Mice were restrained and tail vein injections were performed with 100 ml at 106 cells per ml. Mice
were not fed doxycycline—Dox (+) cells were treated for 24 hr before injections with 200 ng/ml in
complete media. For bioluminescence imaging, mice were injected i.p. with D-luciferin at 15 mg/kg,
anesthetized with 2.5% isofluorane and luciferin was allowed to circulate for 10 min prior to live ani-
mal imaging on an IVIS Spectum imaging system (PerkinElmer, Waltham, MA). Sample sizes were
determined using a two-sample test, a power of 0.90, and a Type I error of 0.05 with data collected
from pilot studies.
Histology
Paraffin-embedded lung tissues were sectioned, deparaffinized, and stained with hematoxylin and
eosin before imaging.
Immunohistochemistry
Paraffin-embedded lung tissues were sectioned at 5 mm, deparaffinized, and rehydrated using
graded ethanol washes. Sodium citrate buffer was used for antigen retrieval. Sections were blocked
with BSA then incubated with primary antibodies overnight. Anti-mApple antibodies were from
Abcam (Cambridge, UK) and used as recommended. Biotinylated secondary antibodies were from
Cell Signaling Technology and used as recommended. DAB peroxidase substrate kit from Vector
Labs (Burlingame, CA) was used as recommended. Sections were then dehydrated using graded eth-
anol washes and mounted in Permount (Sigma). Mounted sections were imaged by light microscopy.
Immunofluorescence
Paraffin-embedded lung tissues were sectioned at 5 mm, deparaffinized, and rehydrated using
graded ethanol washes. Sodium citrate buffer was used for antigen retrieval. Sections were blocked
with BSA then incubated with primary antibodies overnight. pH3 antibodies were from Cell Signaling
Technology and used as recommended. Fluorescent secondary antibodies were from Jackson Immu-
noResearch (West Grove, PA) and used as recommended. Sections were wet-mounted then imaged
by confocal microscopy.
Quantification of immunofluorescence
After microscopy, images were analyzed using ImageJ software. DAPI-stained nuclei were counted
using the ‘Analyze particles’ tool. Signal from antibodies of interest was measured using the ‘Mea-
sure’ tool set to output ‘mean’ pixel intensity. Quotients were obtained by dividing either the
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number of positive nuclei (pH3) or mean pixel intensity (other antibodies) by the number of nuclei—
thereby accounting for tumor density or size in our image analysis. Quotients were normalized to
negative controls and plotted as normalized average signal per cell.
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